Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Infectious Diseases|November 1, 1996
Efficacy of high-titer live attenuated varicella vaccine in healthy young childrenT Varis, T Vesikari
European Journal of Clinical Pharmacology|June 15, 2000
The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisoloneT Varis, K T Kivistö, P J Neuvonen
European Journal of Clinical Pharmacology|October 26, 2000
Grapefruit juice can increase the plasma concentrations of oral methylprednisoloneT Varis, K T Kivistö, P J Neuvonen
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1995
Comparison of enzyme immunoassay antigen detection, nucleic acid hybridization and PCR assay in the diagnosis of Chlamydia trachomatis infectionA Miettinen, P Vuorinen, T Varis, et al.
Pharmacology & Toxicology|July 30, 1999
Itraconazole decreases the clearance and enhances the effects of intravenously administered methylprednisolone in healthy volunteersT Varis, K T Kivistö, J T Backman, et al.
Clinical Pharmacology and Therapeutics|March 31, 2000
Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisoloneT Varis, J T Backman, K T Kivistö, et al.
Clinical Pharmacology and Therapeutics|November 3, 1998
Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazoleT Varis, K M Kaukonen, K T Kivistö, et al.
Vaccine|May 1, 1991
Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificityT Vesikari, T Varis, K Green, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effectT Varis, K T Kivistö, J T Backman, et al.
American Journal of Diseases of Children (1960)|March 1, 1990
Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of ageT Vesikari, T Rautanen, T Varis, et al.
Pageof 2